Your browser doesn't support javascript.
loading
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial.
Connolly, Stuart J; Eikelboom, John W; Bosch, Jackie; Dagenais, Gilles; Dyal, Leanne; Lanas, Fernando; Metsarinne, Kaj; O'Donnell, Martin; Dans, Anthony L; Ha, Jong-Won; Parkhomenko, Alexandr N; Avezum, Alvaro A; Lonn, Eva; Lisheng, Liu; Torp-Pedersen, Christian; Widimsky, Petr; Maggioni, Aldo P; Felix, Camilo; Keltai, Katalin; Hori, Masatsugu; Yusoff, Khalid; Guzik, Tomasz J; Bhatt, Deepak L; Branch, Kelley R H; Cook Bruns, Nancy; Berkowitz, Scott D; Anand, Sonia S; Varigos, John D; Fox, Keith A A; Yusuf, Salim.
Afiliación
  • Connolly SJ; Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada. Electronic address: connostu@phri.ca.
  • Eikelboom JW; Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada.
  • Bosch J; School of Rehabilitation Science, McMaster University, Hamilton, ON, Canada.
  • Dagenais G; Institut Universitaire de Cardiologie et Pneumologie de Québec, Québec, QC, Canada.
  • Dyal L; Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada.
  • Lanas F; Universidad de la Frontera, Temuco, Chile.
  • Metsarinne K; Department of Medicine, Turku University Central Hospital and Turku University, Turku, Finland.
  • O'Donnell M; Department of Medicine, National University of Ireland, Galway, Ireland.
  • Dans AL; Department of Medicine, University of Philippines, Manila, Philippines.
  • Ha JW; Yonsei University College of Medicine, Seoul, Korea.
  • Parkhomenko AN; Institute of Cardiology, Kiev, Ukraine.
  • Avezum AA; Instituto Dante Pazzanese de Cardiologia & University Santo Amaro, Saõ Paulo, Brazil.
  • Lonn E; Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada.
  • Lisheng L; FuWai Hospital, CAMS, Beijing, China.
  • Torp-Pedersen C; University of Aalborg, Aalborg, Denmark.
  • Widimsky P; Charles University, Prague, Czech Republic.
  • Maggioni AP; ANMCO Research Center, Florence, Italy.
  • Felix C; Universidad Tecnológica Equinoccial, Facultad de Ciencias de la Salud Eugenio, Espejo, Quito, Ecuador.
  • Keltai K; Department of Medicine, Semmelweis University, Budapest, Hungary.
  • Hori M; Osaka International Cancer Institute, Osaka, Japan.
  • Yusoff K; Universiti Teknologi Mara, Selangor, Malaysia.
  • Guzik TJ; Collegium Medicum Jagiellonian University, Krakow, Poland; University of Glasgow, Glasgow, UK.
  • Bhatt DL; Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School, Boston, MA, USA.
  • Branch KRH; Department of Medicine, University of Washington Medical Centre, Seattle, WA, USA.
  • Cook Bruns N; Bayer AG, Wuppertal, Germany.
  • Berkowitz SD; Bayer AG, Parsippany, NJ, USA.
  • Anand SS; Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada.
  • Varigos JD; Monash University, Melbourne, VIC, Australia.
  • Fox KAA; Department of Medicine, University of Edinburgh, Edinburgh, UK.
  • Yusuf S; Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada.
Lancet ; 391(10117): 205-218, 2018 01 20.
Article en En | MEDLINE | ID: mdl-29132879
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Terapias_biologicas / Aromoterapia Asunto principal: Enfermedad de la Arteria Coronaria / Inhibidores de Agregación Plaquetaria / Aspirina / Inhibidores del Factor Xa / Rivaroxabán Tipo de estudio: Clinical_trials Idioma: En Revista: Lancet Año: 2018 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Terapias_biologicas / Aromoterapia Asunto principal: Enfermedad de la Arteria Coronaria / Inhibidores de Agregación Plaquetaria / Aspirina / Inhibidores del Factor Xa / Rivaroxabán Tipo de estudio: Clinical_trials Idioma: En Revista: Lancet Año: 2018 Tipo del documento: Article